We are looking for healthy people to assist our medical research into a new medication that may be successful in treating pancreatic cancer as well as Idiopathic Pulmonary Fibrosis (IPF), a condition where the lung tissue becomes damaged and scarred.

8 nights
1 visits

These conditions do not currently have many treatment options, and the medications that are available are not very effective. The medication in this study is given as an oral tablet and is designed to reduce cancer spreading and the fibrosis (scarring) of lung tissue. For the initial stage of research into this medication, we require healthy participants with no medical conditions. This is so we can look at how the body metabolises the medication. At a later stage, it is hoped the medication will go on to be tested in patients with these conditions. With an inpatient stay of 8 days and only 1 outpatient visit, the entire study is over in 2 weeks.

This clinical trial has been approved by an independent ethics committee, and eligible participants will be reimbursed for their time.

This study requires male participants to provide semen samples. To read more about this, click here.

Call us on 1800 243 733 to discuss your eligibility today!


Biological Sex Healthy males or females
Age Males aged 50 - 65 years old, Females 18 - 50 years old
BMI 18 - 30 kg/m²
Body Weight > 50 kg
Medication Not taking any medication
Medical History Nothing significant
Smoking History Non-smokers or occasional smokers (no more than 2 cigarettes per week)